Seaport raises $225m to advance portfolio of neuropsychiatric prodrugs
The funding will support Seaport’s technology platform, which helps drugs be absorbed more efficiently through the lymphatic system.
The funding will support Seaport’s technology platform, which helps drugs be absorbed more efficiently through the lymphatic system.
What's Your Reaction?
